We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Ixico Plc (IXI) New Ord GBP0.01

Sell:8.50p Buy:8.75p 0 Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:8.50p
Buy:8.75p
Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:8.50p
Buy:8.75p
Change: No change
Market closed Prices as at close on 26 April 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

IXICO plc is a United Kingdom-based company that provides specialist data analytics services to the global biopharmaceutical industry. The services include the collection, analysis, management, and reporting on data generated in the course of a clinical study. The outputs from the data analysis are used to enhance patient selection, monitor drug safety, and assess clinical efficacy of the drug under development. It offers a range of services, such as drug development analytics, imaging operations, post-marketing, and post-marketing. It offers end to end services, including trial design and consultation, project management, imaging site set-up and management, data management, reading and analysis, and regulatory pathway. It offers a range of clinical trial imaging analysis tools, including radiological reads, structural and advanced magnetic resonance imaging (MRI). Its specialist data analytics services identify and measure biomarkers from brain scans and wearable biosensors.

Contact details

Address:
4th Fl, Griffin Court, 15 Long Lane
LONDON
EC1A 9PN
United Kingdom
Telephone:
+44 (020) 37637499
Website:
https://ixico.com/

Important dates

Future events
There are no future events available.
Past events
Trading Announcement 13 March 2024 13/03/24
AGM 25 January 2024 25/01/24
Final results 05 December 2023 05/12/23
Trading Announcement 29 September 2023 29/09/23
Interim results 23 May 2023 23/05/23
Trading Announcement 10 May 2023 10/05/23

General stock information

EPIC:
IXI
ISIN:
GB00BFXR4C20
Market cap:
£4.17 million
Shares in issue:
48.35 million
Sector:
Pharmaceuticals & Biotechnology
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Giulio Cerroni
    Chief Executive Officer, Executive Director
  • Grant Nash
    Chief Financial Officer, Executive Director, Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.